Curcumin attenuates di(2-ethylhexyl) phthalate-induced hepatic injury in chicks via oxidative stress, glycolysis, and PANoptosis-related signaling Authors: Xiaoyu Zhao, Bolin Zhao, Bin Li, Rong Guo, Yue Liu, Li Liu, Yue Xu, Guangxing Li, Xiaodan Huang Published: 2026 ABSTRACT Curcumin is a natural polyphenol with hepatoprotective potential, whereas di(2-ethylhexyl) phthalate (DEHP) is a widely used environmental plasticizer that poses a threat to poultry liver health. This study investigated the protective effects of curcumin against DEHP-induced hepatic injury in chickens and examined the involvement of reactive oxygen species (ROS)-dependent hypoxia-inducible factor 1 alpha (HIF-1α)-mediated glycolysis and PANoptosis-related molecular responses. In vitro, Curcumin attenuated DEHP-induced mitochondrial ROS overproduction, restored ATP generation and mitochondrial membrane potential, improved calcium homeostasis, and alleviated mitochondrial dysfunction and endoplasmic reticulum stress. Curcumin also suppressed DEHP-induced HIF-1α, HK2, PKM, and LDH expression, whereas ROS activation weakened these effects. Glycolysis inhibition further reduced apoptosis-, necroptosis-, and pyroptosis-related molecular markers, highlighting a regulatory role of the ROS-HIF-1α-glycolysis axis. In vivo, DEHP exposure decreased body weight while increasing the liver index and serum activities of alanine aminotransferase and aspartate aminotransferase. It also induced pronounced hepatic histological and ultrastructural damage, accompanied by oxidative stress, inflammatory responses, mitochondrial dysfunction, glycolytic activation, and PANoptosis-related molecular responses. Curcumin supplementation substantially ameliorated these pathological changes by restoring antioxidant capacity, preserving mitochondrial function and metabolic homeostasis, suppressing the expression of inflammatory cytokines, and attenuating programmed cell death-related molecular markers. Furthermore, network pharmacology, molecular docking, molecular dynamics simulation, and cellular thermal shift assay consistently identified HIF-1α as a potential molecular target underlying the hepatoprotective effects of curcumin. Collectively, these findings demonstrate that curcumin effectively protects against DEHP-induced hepatic injury in chickens, at least in part, by suppressing ROS accumulation, inhibiting HIF-1α-mediated glycolytic disorder, and consequently attenuating downstream PANoptosis-related molecular responses. Introduction The liver is a vital organ responsible for nutrient metabolism, detoxification, antioxidant defense, and immune regulation in poultry (Surai et al., 2019; Zaefarian et al., 2019). Maintaining hepatic structure integrity and physiological function is therefore essential for chick growth, metabolic homeostasis, and overall health (Surai et al., 2019; Gržinić et al., 2023). Nevertheless, poultry are continuously exposed to environmental contaminants from feed, water, dust, plastic materials, and production environments (Gržinić et al., 2023). Among these pollutants, di(2-ethylhexyl) phthalate (DEHP), a commonly used phthalate plasticizer, has attracted considerable attention due to its extensive application and environmental risks. Since DEHP is not chemically bound to polymer matrices, it can readily migrate from plastic materials into the environment (Van Vliet et al., 2011; Rowdhwal and Chen, 2018). Its persistence and bioaccumulation potential have led to its recognition as an endocrine-disrupting chemical with adverse effects on animal health (Latini et al., 2004; Zhang et al., 2019a). The liver is particularly susceptible to DEHP toxicity as the major site of xenobiotic metabolism and detoxification (Zhang et al., 2019b; Li et al., 2023). Previous studies have demonstrated that DEHP exposure induces oxidative stress, inflammatory responses, mitochondrial dysfunction, and hepatocellular injury (Li et al., 2021; Xu et al., 2024). Mitochondria are essential regulators of hepatic energy metabolism and cell fate determination (Middleton and Vergis, 2021; Chen et al., 2024). Under toxic or inflammatory stress, mitochondrial homeostasis can be disrupted, resulting in excessive mitochondrial reactive oxygen species production, mitochondrial membrane potential loss, calcium dyshomeostasis, and impaired adenosine triphosphate generation (Auger et al., 2015; Shi et al., 2021). Mitochondrial impairment is also associated with altered mitochondrial dynamics, including enhanced fission and reduced fusion, which are primarily controlled by dynamin-related protein 1 and mitofusin 2 (Ramachandran et al., 2021; Chen et al., 2023). Moreover, excessive reactive oxygen species accumulation can stabilize hypoxia-inducible factor 1 alpha, a key regulator of cellular metabolic adaptation under stress conditions (Jung et al., 2008; DeMichele et al., 2024). Activated hypoxia-inducible factor 1 alpha promotes the expression of glycolysis-related enzymes, including hexokinase 2, pyruvate kinase M, and lactate dehydrogenase, thereby shifting the energy metabolism from oxidative phosphorylation toward glycolysis (Corcoran and O’Neill, 2016; Yuan et al., 2024). This glycolytic disorder may further exacerbate hepatic inflammation and cellular injury (Qu et al., 2023). Programmed cell death is another important mechanism contributing to toxicant-induced tissue injury. Although apoptosis, necroptosis, and pyroptosis were initially considered independent pathways, accumulating evidence indicates that these processes are under conditions of inflammation and cellular stress (Fritsch et al., 2019; Pandian and Kanneganti, 2022). PANoptosis is an inflammatory programmed cell death pathway characterized by the coordinated activation of apoptosis-, necroptosis-, and pyroptosis-associated molecular events (Zhu et al., 2023; Shi et al., 2023). This process is closely associated with mitochondrial dysfunction, oxidative stress, inflammasome activation, and inflammatory cytokine release (Salminen et al., 2012; Kuriakose et al., 2016). However, whether DEHP induces PANoptosis-related molecular alterations in chicken liver and whether these alterations are mediated through hypoxia-inducible factor 1 alpha-driven glycolytic dysregulation remain unclear. (Ghosh et al., 2010; Zhang et al., 2020). Curcumin is a natural polyphenolic compound extracted from turmeric with antioxidant, anti-inflammatory, and hepatoprotective properties (Hewlings and Kalman, 2017; Dehzad et al., 2023). It has been reported to alleviate oxidative stress, mitochondrial dysfunction, inflammatory injury, and metabolic disorders in various models (Farzaei et al., 2018; Wang et al., 2019). These properties suggest that curcumin may be a promising nutritional strategy for protecting poultry against contaminant-induced hepatic injury (Zhai et al., 2020; Damiano et al., 2021; Wu et al., 2023). Nevertheless, the protective effect against DEHP-induced hepatic injury in chickens, particularly regarding the ROS-HIF-1α axis, glycolytic disorder, and PANoptosis-related molecular responses, remains unclear. Therefore, the present study aimed to determine whether curcumin alleviates DEHP-induced hepatic injury in LMH cells and chickens and to investigate the molecular mechanisms potentially underlying its protective effects. Specifically, we examined whether mitochondrial oxidative stress and ROS-dependent HIF-1α-mediated glycolytic alterations are involved in the protective effects of curcumin. Pharmacological activation of ROS and inhibition of glycolysis were further employed to evaluate the functional relationships among ROS accumulation, glycolytic regulation, and apoptosis-, necroptosis-, and pyroptosis-related molecular responses. By integrating in vitro mechanistic interventions with in vivo validation, this study provides experimental evidence for the metabolic mechanisms underlying the hepatoprotective effects of curcumin and supports its potential application as a nutritional strategy for mitigating plasticizer-associated hepatic injury in poultry. Materials and methods Animals and treatment All animal experiments were performed in accordance with the guidelines established by the Animal Ethics Committee of Northeast Agricultural University and were approved under protocol number NEAUEC20220339. Forty 1-day-old Hy-Line White chicks were obtained from Harbin, China, and housed at the Biomedical Research Center of Northeast Agricultural University. Throughout the experiment period, all chicks were provided with ad libitum access to feed and water. Following a 7-day acclimation period, the chicks were randomly allocated into four experimental groups (n = 10 per group): the control group (Con), receiving corn oil by gavage; the curcumin group (Cur), receiving curcumin at a dose of 200 mg/kg body weight/day by gavage; the DEHP group, receiving DEHP at 1,600 mg/kg body weight/day by gavage; and the DEHP plus curcumin group (C+D), receiving both curcumin and DEHP via gavage. After 35 consecutive days of administration, the chicks were euthanized, and liver tissues were immediately collected. The liver index was calculated using the following formula: liver index (%) = liver weight (g) / body weight (g) × 100. Collected liver tissues were rinsed with 0.9% saline and accurately weighed. Representative liver samples were fixed in 4% formaldehyde for hematoxylin and eosin staining, preserved in glutaraldehyde for transmission electron microscopy analysis, or immediately stored at −80 °C for subsequent RNA and protein extraction. In addition, blood samples were collected and isolated for the measurement of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, as well as oxidative stress-related indicators. Hematoxylin and eosin staining Liver tissues were fixed in 4% formaldehyde for 24 h and subsequently subjected to a series of procedures, including graded ethanol dehydration, xylene clearing, paraffin embedding, and sectioning. Paraffin-embedded tissue sections (4 μm thickness) were prepared and routinely stained with hematoxylin and eosin. The histopathological alterations in liver tissues were examined using a light microscope (Nikon, Japan). Transmission electron microscopy Liver tissues were processed for ultrastructural analysis, and ultrathin sections with a thickness of 50-60 nm were prepared. The sections were subsequently examined using a transmission electron microscope (GEM1200ES, Japan) to evaluate ultrastructural changes and alterations in hepatic tissue morphology. Network pharmacology analysis The chemical structure of curcumin, including its SMILES string, was obtained from the PubChem database. The SMILES sequence was uploaded to the SwissTargetPrediction and TargetNet databases to predict potential targets. Liver injury-related targets were collected from the GeneCards database and standardized using the UniProt database. Species conversion was then performed using the STRING database to map the targets to Gallus gallus, thereby obtaining potential curcumin-related targets in chickens. The overlapping targets were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses using the Microbioinformatics platform. A protein–protein interaction (PPI) network was subsequently constructed with Cytoscape software to analyze the interactions among the intersecting targets. Molecular docking and molecular dynamics simulation The three-dimensional structure of HIF-1α was obtained from a public protein structure database in PDB format and imported into AutoDock software for molecular docking analysis. The docking poses were visualized using PyMOL software. To further evaluate the stability of the curcumin–HIF-1α complex, a 100 ns molecular dynamics simulation was performed. The system was equilibrated under NVT and NPT ensembles at 1 bar for 50,000 steps (100 ps) using the Berendsen pressure coupling and V-rescale temperature coupling method. The Verlet buffer algorithm was applied with a cutoff radius of 1.2 nm, and the neighbor list was updated every 10 steps. During the production phase, a 2 fs time step was adopted, and trajectories were recorded every 10 ps. The stability and binding characteristics of the complex were evaluated based on binding free energy and residue decomposition energy analyses. Cell culture and treatment LMH cells maintained in our laboratory were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (Gibco, USA) at 37 °C in a humidified incubator containing 5% CO2. Cell viability was evaluated using the Cell Counting Kit-8 (CCK-8) assay. Briefly, LMH cells were seeded into 96-well plates and exposed to different concentrations of DEHP for 24 h, or co-treated with DEHP, curcumin, sanguinarine chloride (SC), and sodium dichloroacetate (SD) at the designated concentrations. Subsequently, 10 μL of the CCK-8 working solution (Meilun, China) was added to each well, followed by incubation for an additional 30 min. The absorbance was measured at 450 nm using a microplate reader (BioTek, USA), and cell viability was determined according to the manufacturer’s protocol.SC was employed as a pharmacological ROS activator because it promotes intracellular ROS accumulation. It was used to determine whether increased ROS production could attenuate or reverse the protective effects of curcumin. SD, an inhibitor of pyruvate dehydrogenase kinase, promotes pyruvate oxidation and reduces cellular dependence on glycolysis. It was therefore used to investigate whether inhibition of DEHP-induced glycolytic activation affected apoptosis-, necroptosis-, and pyroptosis-related molecular responses. The final treatment groups were as follows: Con (0 μM), Cur (10 μM), DEHP (40 μM), SC (1 μM), SD (2 μM), C+D (10 μM curcumin + 40 μM DEHP), C+D+SC (10 μM curcumin + 40 μM DEHP + 1 μM SC), and D+SD (40 μM DEHP + 2 μM SD). Cellular thermal shift assay For the cellular thermal shift assay (CETSA), cells in the Con group were cultured in regular medium, whereas those in the Cur group were treated with 10 μM curcumin for 24 h. Cell lysates were then prepared, heated at 37-67 °C for 3 min, mixed with 5× SDS loading buffer, and boiled for 10 min before Western blot analysis. Determination of oxidative stress indicators Commercial assay kits (Nanjing Jiancheng Bioengineering Institute, China) were used to measure serum malondialdehyde (MDA) content, superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) activity, and total antioxidant capacity (T-AOC), according to the manufacturer’s instructions. Immunofluorescence staining LMH cells were seeded into 24-well plates and treated according to the designated groups for 24 h after treatment. The culture medium was discarded, and the cells were washed three times with PBS before fixation with 4% paraformaldehyde overnight at 4 °C. The fixed cells were washed with PBS, permeabilized with Triton X-100 for 30 min at room temperature, and blocked with 5% BSA for 1.5 h. Cells were then incubated overnight at 4 °C with primary antibodies against Caspase-3, RIPK1, or NLRP3 (1:150). After three washes with TBST (5 min each), fluorescent secondary antibodies (1:500) were added and incubated for 1 h in the dark. After further washing, nuclei were counterstained with DAPI for 15 min in the dark. Finally, cells were washed with PBS, and images were acquired using a fluorescence microscope. Measurement of mitochondrial reactive oxygen species LMH cells were seeded into 6-well plates and treated as indicated for 24 h. Mitochondrial reactive oxygen species were detected using MitoSOX Red (MedChemExpress, Shanghai, China). Briefly, the MitoSOX stock solution was diluted with serum-free medium to a final concentration of 1 μmol/L. After removal of the culture medium, cells were washed three times with PBS and incubated with 1 mL of MitoSOX Red working solution at 37 °C for 15 min. After incubation, the cells were washed twice with PBS and immediately observed under a fluorescence microscope. Measurement of mitochondrial membrane potential LMH cells were uniformly seeded into 6-well plates and subjected to the indicated treatments for 24 h. Mitochondrial membrane potential was evaluated using the JC-1 fluorescent probe (MedChemExpress, Shanghai, China). The JC-1 stock solution was diluted to a final concentration of 5 μg/mL. After removal of the culture medium, cells were washed with PBS and incubated with 1 mL of JC-1 working solution at 37 °C for 20 min in the dark. After incubation, the cells were washed with PBS and examined using a fluorescence microscope. The ratio of JC-1 aggregate fluorescence to JC-1 monomer fluorescence was used to indicate mitochondrial membrane potential. Measurement of ATP content Intracellular ATP content was determined using a commercial ATP assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) strictly according to the manufacturer’s instructions. Quantitative real-time PCR analysis Total RNA was extracted from LMH cells and liver tissues, followed by reverse transcription using PrimeScript RT Master Mix (RR036A; Takara, Beijing, China). Quantitative real-time PCR was performed on a LightCycler 480 system (Roche, Switzerland), with β-actin selected as the internal reference gene. The relative expression levels of target genes were calculated using the 2^−ΔΔCt method. The primer sequences used for quantitative real-time PCR analysis are provided in Table S1. Western blot analysis Total protein was extracted from tissues and cells using RIPA lysis buffer containing PMSF. Protein concentrations were determined using a BCA protein assay kit (Beiaotianmei, China). Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes, blocked at 37 °C for 2 h, and incubated overnight at 4 °C with primary antibodies. The membranes were then incubated with HRP-conjugated secondary antibodies for 2 h. Protein band intensities were quantified using ImageJ software. Antibody information and dilution ratios are listed in Table S2. Statistical analysis All experiments were performed with at least three independent replicates. Data are presented as mean ± SD. Statistical analyses were performed using GraphPad Prism 10.1.2. Normality and homogeneity of variance were assessed using the Shapiro–Wilk and Levene’s test, respectively. Body weight was analyzed by repeated-measures ANOVA, while one-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Statistical significance was defined as P < 0.05. Results Curcumin alleviates DEHP-induced mitochondrial dysfunction in LMH cells by inhibiting ROS The effects of DEHP, curcumin, SC (sanguinarine chloride), and SD (sodium dichloroacetate) on LMH cell viability were first detected using the CCK-8 assay. Based on the viability results, 40 μM DEHP, 10 μM curcumin, 1 μM SC, and 2 μM SD were selected for subsequent in vitro experiments (Fig. 1A–D, P < 0.05). MitoSOX Red staining showed that DEHP markedly increased mitochondrial ROS levels, whereas curcumin significantly reduced ROS accumulation. In contrast, curcumin treatment significantly attenuated the DEHP-induced increase in mitochondrial ROS, whereas SC-mediated ROS activation largely abolished this protective effect (Fig. 1E and F, P < 0.05). Consistently, DEHP significantly reduced intracellular ATP production, while curcumin partially restored ATP levels (Fig. 1G, P < 0.05). To further investigate mitochondrial injury, mitochondrial dynamics- and endoplasmic reticulum stress-related indicators were examined. DEHP markedly increased DRP1 expression and decreased MFN2 expression at both the mRNA and protein levels, indicating excessive mitochondrial fission and impaired fusion. Curcumin effectively reversed these alterations, whereas SC treatment increased DRP1 and decreased MFN2 expression in the C+D+SC group (Fig. 1H–J, P < 0.05). DEHP also significantly increased CHOP expression and the p-PERK/PERK ratio, suggesting activation of endoplasmic reticulum stress, while curcumin suppressed these changes. SC-mediated ROS activation partially restored CHOP expression and PERK phosphorylation (Fig. 1I and J, P < 0.05). JC-1 staining further demonstrated that DEHP induced a marked loss of mitochondrial membrane potential, whereas curcumin alleviated mitochondrial depolarization. This protective effect was weakened by SC treatment (Fig. 1K and L, P < 0.05). Similarly, MitoTracker/Fluo-4 co-staining showed that DEHP increased intracellular calcium levels, while curcumin restored calcium homeostasis. Notably, calcium fluorescence intensity increased again after SC treatment in the C+D+SC group (Fig. 1M and N, P < 0.05). Collectively, these findings demonstrate that DEHP induces mitochondrial dysfunction through excessive ROS accumulation, whereas curcumin protects LMH cells by suppressing ROS-mediated mitochondrial injury.Fig. 1Effects of curcumin, DEHP, and pathway-modulating treatments on mitochondrial oxidative stress, mitochondrial function, and endoplasmic reticulum stress in LMH cells. (A to D) Cell viability of LMH cells treated with different concentrations of DEHP, curcumin (Cur), SC, or SD. (E) Representative images of MitoSOX Red staining and corresponding three-dimensional fluorescence intensity plots. (F) Quantitative analysis of MitoSOX fluorescence intensity. (G) ATP content. (H) Relative mRNA expression levels of DRP1 and MFN2. (I) Representative Western blot bands of DRP1, MFN2, CHOP, PERK, p-PERK, and GAPDH. (J) Quantitative analysis of DRP1, MFN2, CHOP, and p-PERK/PERK protein levels. (K) Representative images of JC-1 staining and corresponding three-dimensional fluorescence intensity plots. (L) Quantitative analysis of JC-1 fluorescence intensity. (M) Representative images of MitoTracker/Fluo-4 staining and corresponding three-dimensional fluorescence intensity plots. (N) Quantitative analysis of fluorescence intensity. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are shown in the corresponding images.Fig 1 dummy alt text Effects of curcumin, DEHP, and pathway-modulating treatments on mitochondrial oxidative stress, mitochondrial function, and endoplasmic reticulum stress in LMH cells. (A to D) Cell viability of LMH cells treated with different concentrations of DEHP, curcumin (Cur), SC, or SD. (E) Representative images of MitoSOX Red staining and corresponding three-dimensional fluorescence intensity plots. (F) Quantitative analysis of MitoSOX fluorescence intensity. (G) ATP content. (H) Relative mRNA expression levels of DRP1 and MFN2. (I) Representative Western blot bands of DRP1, MFN2, CHOP, PERK, p-PERK, and GAPDH. (J) Quantitative analysis of DRP1, MFN2, CHOP, and p-PERK/PERK protein levels. (K) Representative images of JC-1 staining and corresponding three-dimensional fluorescence intensity plots. (L) Quantitative analysis of JC-1 fluorescence intensity. (M) Representative images of MitoTracker/Fluo-4 staining and corresponding three-dimensional fluorescence intensity plots. (N) Quantitative analysis of fluorescence intensity. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are shown in the corresponding images. Curcumin suppresses DEHP-induced glycolytic dysregulation in LMH cells through the ROS-HIF-1α axis To determine whether ROS is involved in HIF-1α-mediated glycolytic regulation, the expression of glycolysis-related genes was examined after SC treatment. DEHP exposure significantly increased the mRNA levels of HIF-1α, HK2, PKM, and LDH compared with the control group, whereas curcumin markedly suppressed these increases (Fig. 2A, P < 0.05). However, SC-mediated ROS activation significantly restored the expression of these genes compared with the C+D group (P < 0.05). Consistent with the transcriptional results, DEHP increased the protein expression of HIF-1α, HK2, PKM, and LDH, while curcumin effectively attenuated these changes. Notably, SC treatment partially abolished the inhibitory effects of curcumin on these glycolysis-related proteins (Fig. 2C and D, P < 0.05). ATP analysis further showed that DEHP reduced intracellular ATP production, which was partially restored by curcumin; however, this restoration was weakened following SC treatment under C+D conditions (Fig. 2E, P < 0.05).Fig. 2Effects of SC and SD on the HIF-1α-mediated glycolytic response in DEHP-exposed LMH cells. (A, B) Relative mRNA expression levels of HIF-1α, HK2, PKM, and LDH in LMH cells after SC or SD treatment. (C) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH after SC treatment. (D) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels after SC treatment. (E) ATP content after SC treatment. (F) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH after SD treatment. (G) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels after SD treatment. (H) ATP content after SD treatment. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05).Fig 2 dummy alt text Effects of SC and SD on the HIF-1α-mediated glycolytic response in DEHP-exposed LMH cells. (A, B) Relative mRNA expression levels of HIF-1α, HK2, PKM, and LDH in LMH cells after SC or SD treatment. (C) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH after SC treatment. (D) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels after SC treatment. (E) ATP content after SC treatment. (F) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH after SD treatment. (G) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels after SD treatment. (H) ATP content after SD treatment. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). To further clarify the contribution of glycolysis to DEHP-induced LMH cell injury, the glycolysis inhibitor SD was used. DEHP significantly upregulated the mRNA expression of HIF-1α, HK2, PKM, and LDH, whereas SD markedly reduced their expression under DEHP exposure (Fig. 2B, P < 0.05). Western blot analysis showed similar trends, with SD significantly decreasing the protein levels of HIF-1α, HK2, PKM, and LDH compared with the DEHP group (Fig. 2F and G, P < 0.05). In addition, DEHP decreased intracellular ATP content, while SD further affected cellular energy metabolism by inhibiting glycolytic activity (Fig. 2H, P < 0.05). Collectively, these SC and SD intervention results indicate that ROS may act upstream of HIF-1α-mediated glycolytic activation, and that glycolysis inhibition suppresses DEHP-induced metabolic alterations. These findings suggest that curcumin may alleviate DEHP-induced LMH cell injury through regulation of the ROS–HIF-1α–glycolysis axis. Curcumin reduces DEHP-induced PANoptosis-related molecular responses in LMH cells To investigate whether glycolysis activation contributes to DEHP-induced PANoptosis-related molecular responses, the glycolysis inhibitor SD was employed. As shown in Fig. 3A, DEHP exposure significantly increased the mRNA expression levels of Cas3, MLKL, RIPK1, NLRP3, and GSDMD, while markedly decreasing BCL-2 expression. Curcumin treatment alleviated these changes. Likewise, compared with the DEHP group, SD treatment significantly downregulated the expression of Cas3, MLKL, RIPK1, NLRP3, and GSDMD and partially restored BCL-2 expression. The transcriptional findings were further validated by Western blot analysis. DEHP exposure significantly increased the protein expression levels of Caspase-3, MLKL, RIPK1, GSDMD, and NLRP3, while significantly reducing Bcl-2 expression. Curcumin treatment reduced the activation of these PANoptosis-related proteins. Similarly, SD treatment significantly decreased the protein expression levels of Caspase-3, MLKL, RIPK1, GSDMD, and NLRP3, while restoring Bcl-2 expression compared with the DEHP group (Fig. 3B and C, P < 0.05). Immunofluorescence staining was subsequently performed to further verify the expression of representative PANoptosis-related proteins. As shown in Fig. 3D–I, compared with the control group, DEHP exposure significantly enhanced the fluorescence intensity of Caspase-3, RIPK1, and NLRP3. Curcumin treatment attenuated the fluorescence signals of these proteins. Likewise, SD treatment effectively suppressed the DEHP-induced increases in Caspase-3, RIPK1, and NLRP3 fluorescence intensity (P < 0.05). These results indicate that glycolytic activation is a critical metabolic event linking DEHP-induced PANoptosis-related molecular responses. Furthermore, curcumin appears to alleviate DEHP-induced PANoptosis-related cell injury in LMH cells, at least in part, by suppressing glycolytic activation.Fig. 3Effects of SD on DEHP-induced PANoptosis-related molecular responses in LMH cells. (A) Relative mRNA expression levels of Cas3, BCL-2, MLKL, RIPK1, NLRP3, and GSDMD. (B) Representative Western blot bands of Caspase-3, Bcl-2, MLKL, RIPK1, GSDMD, NLRP3, and GAPDH. (C) Quantitative analysis of Caspase-3, MLKL, GSDMD, Bcl-2, RIPK1, and NLRP3 protein levels. (D) Representative images of Caspase-3 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (E) Quantitative analysis of Caspase-3 fluorescence intensity. (F) Representative images of RIPK1 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (G) Quantitative analysis of RIPK1 fluorescence intensity. (H) Representative images of NLRP3 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (I) Quantitative analysis of NLRP3 fluorescence intensity. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are indicated in the figure.Fig 3 dummy alt text Effects of SD on DEHP-induced PANoptosis-related molecular responses in LMH cells. (A) Relative mRNA expression levels of Cas3, BCL-2, MLKL, RIPK1, NLRP3, and GSDMD. (B) Representative Western blot bands of Caspase-3, Bcl-2, MLKL, RIPK1, GSDMD, NLRP3, and GAPDH. (C) Quantitative analysis of Caspase-3, MLKL, GSDMD, Bcl-2, RIPK1, and NLRP3 protein levels. (D) Representative images of Caspase-3 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (E) Quantitative analysis of Caspase-3 fluorescence intensity. (F) Representative images of RIPK1 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (G) Quantitative analysis of RIPK1 fluorescence intensity. (H) Representative images of NLRP3 immunofluorescence staining and corresponding three-dimensional fluorescence intensity plots. (I) Quantitative analysis of NLRP3 fluorescence intensity. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are indicated in the figure. Curcumin alleviates DEHP-induced liver injury and oxidative stress in chicks The experimental design for the animal study is shown in Fig. 4A. Throughout the experiment period, body weight increased progressively in all groups with age. However, chicks exposed to DEHP exhibited significantly lower body weights than those in the control group, with the growth-suppressive effect becoming increasingly evident during the later stage of the experiment. Curcumin supplementation partially restored the DEHP-induced decrease in body weight (Fig. 4B, P < 0.05). Moreover, DEHP exposure markedly increased the liver index, whereas curcumin treatment significantly attenuated this increase (Fig. 4C, P < 0.05). Histopathological examination revealed that the livers of the control and curcumin groups maintained normal architecture, characterized by a well-organized hepatic cord and intact hepatocyte morphology. In contrast, the DEHP group exhibited severe pathological alterations, including disordered hepatic architecture, hepatocyte swelling, inflammatory cell infiltration, and focal tissue damage. These histopathological abnormalities were markedly alleviated following curcumin supplementation (Fig. 4D). Consistent with these observations, transmission electron microscopy further showed that the hepatocyte ultrastructure in the control and curcumin groups was relatively normal, with intact nuclei and mitochondria. Conversely, DEHP exposure induced pronounced mitochondrial swelling, cristae disruption, and other ultrastructural abnormalities, all of which were substantially ameliorated by curcumin treatment (Fig. 4E). Serum biochemical analysis further showed that DEHP exposure significantly elevated ALT and AST activities, indicating hepatic dysfunction, whereas curcumin supplementation effectively reduced the activities of both enzymes compared with the DEHP group (Fig. 4F, P < 0.05). In addition, DEHP exposure markedly increased MDA content while significantly decreasing GSH-Px activity, T-AOC level, and T-SOD activity, demonstrating severe oxidative stress. Curcumin supplementation significantly reduced MDA accumulation and restored antioxidant capacity by enhancing GSH-Px activity, T-AOC, and T-SOD activity (Fig. 4G–J, P < 0.05).Fig. 4Effects of curcumin on growth performance, liver injury, hepatic morphology, ultrastructure, and oxidative stress in DEHP-exposed chicks. (A) Schematic diagram of the animal experimental design. After 7 d of adaptive feeding, Hy-Line chicks were divided into the Con, Cur, DEHP, and C+D groups and treated continuously for 35 d. (B) Changes in chick body weight during the experiment. (C) Liver organ coefficient. (D) Representative hematoxylin-eosin-stained liver sections at magnifications of 10× and 40×. (E) Representative transmission electron microscopy images of liver ultrastructure. (F) Serum ALT and AST activities. (G) MDA content. (H) GSH-Px activity. (I) T-AOC level. (J) T-SOD activity. Data are presented as the mean ± SD. For body weight data, different lowercase letters at the same time point indicate significant differences among treatment groups (P < 0.05). In other panels, different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are indicated in the figure.Fig 4 dummy alt text Effects of curcumin on growth performance, liver injury, hepatic morphology, ultrastructure, and oxidative stress in DEHP-exposed chicks. (A) Schematic diagram of the animal experimental design. After 7 d of adaptive feeding, Hy-Line chicks were divided into the Con, Cur, DEHP, and C+D groups and treated continuously for 35 d. (B) Changes in chick body weight during the experiment. (C) Liver organ coefficient. (D) Representative hematoxylin-eosin-stained liver sections at magnifications of 10× and 40×. (E) Representative transmission electron microscopy images of liver ultrastructure. (F) Serum ALT and AST activities. (G) MDA content. (H) GSH-Px activity. (I) T-AOC level. (J) T-SOD activity. Data are presented as the mean ± SD. For body weight data, different lowercase letters at the same time point indicate significant differences among treatment groups (P < 0.05). In other panels, different lowercase letters indicate significant differences among treatment groups (P < 0.05). Scale bars are indicated in the figure. Curcumin improves DEHP-induced hepatic mitochondrial dysfunction, glycolytic dysregulation, inflammatory responses, and PANoptosis-related molecular responses in chicks To further elucidate the molecular mechanisms underlying the hepatoprotective effects of curcumin, markers associated with mitochondrial dynamics, endoplasmic reticulum stress, inflammation, glycolysis, and PANoptosis were comprehensively evaluated. DEHP exposure significantly increased the mRNA expression of DRP1 while markedly decreasing MFN2 expression, indicating disrupted mitochondrial dynamics. These alterations were effectively reversed by curcumin supplementation (Fig. 5A, P < 0.05). Consistent with the transcriptional findings, Western blot analysis showed that DEHP increased DRP1 and CHOP protein expression, elevated the p-PERK/PERK ratio, and decreased MFN2 protein expression, while curcumin significantly mitigated these changes (Fig. 5D and E, P < 0.05). DEHP exposure also induced a pronounced inflammatory response, as evidenced by the significantly increased mRNA and protein expression levels of IL-6, TNF-α, and IL-1β, accompanied by a marked reduction in TGF-β expression. Curcumin supplementation effectively suppressed the expression of these pro-inflammatory cytokines while partially restoring TGF-β levels (Fig. 5B, F, and G, P < 0.05). Furthermore, DEHP exposure significantly upregulated both the mRNA and protein expression of HIF-1α, HK2, PKM, and LDH, indicating activation of hepatic glycolysis in chicks. These glycolysis-related changes were markedly inhibited by curcumin treatment (Fig. 5C, H, and I, P < 0.05). Combined with the SC and SD intervention experiments in LMH cells, these findings suggest that DEHP-induced ROS accumulation may promote HIF-1α-mediated glycolytic activation, whereas curcumin attenuates this metabolic reprogramming by inhibiting ROS-related signaling.Fig. 5Effects of curcumin on mitochondrial dynamics, endoplasmic reticulum stress, inflammatory responses, glycolysis, and PANoptosis-related molecular responses in the liver of DEHP-exposed chicks. (A) Relative mRNA expression levels of DRP1 and MFN2. (B) Relative mRNA expression levels of IL-6, TNF-α, IL-1β, and TGF-β. (C) Relative mRNA expression levels of HIF-1α, HK2, PKM, and LDH. (D) Representative Western blot bands of DRP1, MFN2, CHOP, PERK, p-PERK, and GAPDH. (E) Quantitative analysis of DRP1, MFN2, CHOP, and p-PERK/PERK protein levels. (F) Representative Western blot bands of IL-6, TNF-α, IL-1β, TGF-β, and GAPDH. (G) Quantitative analysis of IL-6, TNF-α, IL-1β, and TGF-β protein levels. (H) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH. (I) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels. (J) Relative mRNA expression levels of Cas3, BCL-2, MLKL, RIPK1, NLRP3, and GSDMD. (K) Representative Western blot bands of Caspase-3, Bcl-2, MLKL, RIPK1, GSDMD, NLRP3, and GAPDH. (L) Quantitative analysis of Caspase-3, MLKL, GSDMD, Bcl-2, RIPK1, and NLRP3 protein levels. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05).Fig 5 dummy alt text Effects of curcumin on mitochondrial dynamics, endoplasmic reticulum stress, inflammatory responses, glycolysis, and PANoptosis-related molecular responses in the liver of DEHP-exposed chicks. (A) Relative mRNA expression levels of DRP1 and MFN2. (B) Relative mRNA expression levels of IL-6, TNF-α, IL-1β, and TGF-β. (C) Relative mRNA expression levels of HIF-1α, HK2, PKM, and LDH. (D) Representative Western blot bands of DRP1, MFN2, CHOP, PERK, p-PERK, and GAPDH. (E) Quantitative analysis of DRP1, MFN2, CHOP, and p-PERK/PERK protein levels. (F) Representative Western blot bands of IL-6, TNF-α, IL-1β, TGF-β, and GAPDH. (G) Quantitative analysis of IL-6, TNF-α, IL-1β, and TGF-β protein levels. (H) Representative Western blot bands of HIF-1α, HK2, PKM, LDH, and GAPDH. (I) Quantitative analysis of HIF-1α, HK2, PKM, and LDH protein levels. (J) Relative mRNA expression levels of Cas3, BCL-2, MLKL, RIPK1, NLRP3, and GSDMD. (K) Representative Western blot bands of Caspase-3, Bcl-2, MLKL, RIPK1, GSDMD, NLRP3, and GAPDH. (L) Quantitative analysis of Caspase-3, MLKL, GSDMD, Bcl-2, RIPK1, and NLRP3 protein levels. Data are presented as the mean ± SD. Different lowercase letters indicate significant differences among treatment groups (P < 0.05). Finally, DEHP increased the mRNA and protein expression levels of Caspase-3, MLKL, RIPK1, NLRP3, and GSDMD and decreased Bcl-2 expression, while markedly decreasing Bcl-2 expression, indicating activation of PANoptosis-related molecular responses (Fig. 5J–L, P < 0.05). In summary, curcumin alleviates DEHP-induced liver injury by regulating ROS accumulation, mitochondrial function, endoplasmic reticulum stress, inflammatory responses, HIF-1α-mediated glycolysis, and PANoptosis-related molecular events. Bioinformatics and multivariate analyses support the involvement of HIF-1α-related regulation in the protective effects of curcumin To further clarify the potential molecular targets and regulatory mechanisms underlying the hepatoprotective effects of curcumin, integrated bioinformatics and multivariate analyses were performed. The chemical structure of curcumin is shown in Fig. 6A. A total of 295 overlapping targets were identified among curcumin-, DEHP-, and liver injury-related targets (Fig. 6B). Protein–protein interaction analysis indicated that TNF, HIF1A, and several other targets occupied central positions within the network, suggesting their potential regulatory importance (Fig. 6C). KEGG enrichment analysis showed that these targets were mainly associated with inflammation, cell survival, cell death, metabolism, and the HIF-1 signaling pathway (Fig. 6D). Molecular docking predicted a favorable interaction between curcumin and HIF-1α, with a binding energy of −6.7 kcal/mol (Fig. 6E). Consistently, the cellular thermal shift assay showed that curcumin altered the thermal stability of HIF-1α in LMH cells, indicating a potential interaction between curcumin and HIF-1α (Fig. 6F and G). Molecular dynamics simulation further supported the stability of the curcumin–HIF-1α complex during the 100 ns simulation, as indicated by RMSD, SASA, Gibbs free energy landscape, and hydrogen bond analyses (Fig. S1).Fig. 6Identification of HIF-1α-related responses involved in the protective effects of curcumin against DEHP exposure-induced injury through network pharmacology, molecular docking, thermal stability assays, and integrated correlation analysis. (A) Chemical structure of curcumin. (B) Venn diagram showing the overlapping targets among curcumin-related targets, DEHP-related targets, and disease-related targets. (C) Protein-protein interaction network of overlapping targets. (D) KEGG pathway enrichment analysis of overlapping targets. (E) Molecular docking model showing the predicted interaction between curcumin and HIF-1α. (F) Representative cellular thermal shift assay bands of HIF-1α in LMH cells treated with curcumin or control medium under different temperature conditions. (G) Quantitative analysis of the relative abundance of HIF-1α in the cellular thermal shift assay. (H) Principal component analysis based on the measured indicators of each treatment group. (I) Heatmap showing the expression patterns of selected molecular indicators in each treatment group. (J) Correlation matrix among glycolysis-related, mitochondrial function-related, inflammatory response-related, and PANoptosis-related indicators. (K) Chord diagram showing correlations among selected indicators.Fig 6 dummy alt text Identification of HIF-1α-related responses involved in the protective effects of curcumin against DEHP exposure-induced injury through network pharmacology, molecular docking, thermal stability assays, and integrated correlation analysis. (A) Chemical structure of curcumin. (B) Venn diagram showing the overlapping targets among curcumin-related targets, DEHP-related targets, and disease-related targets. (C) Protein-protein interaction network of overlapping targets. (D) KEGG pathway enrichment analysis of overlapping targets. (E) Molecular docking model showing the predicted interaction between curcumin and HIF-1α. (F) Representative cellular thermal shift assay bands of HIF-1α in LMH cells treated with curcumin or control medium under different temperature conditions. (G) Quantitative analysis of the relative abundance of HIF-1α in the cellular thermal shift assay. (H) Principal component analysis based on the measured indicators of each treatment group. (I) Heatmap showing the expression patterns of selected molecular indicators in each treatment group. (J) Correlation matrix among glycolysis-related, mitochondrial function-related, inflammatory response-related, and PANoptosis-related indicators. (K) Chord diagram showing correlations among selected indicators. Principal component analysis clearly distinguished the control, curcumin, DEHP, and DEHP plus curcumin groups, with PC1, PC2, and PC3 explaining 82.7%, 12.2%, and 3.8% of the total variation, respectively (Fig. 6H). The circular heatmap showed distinct expression patterns of markers related to mitochondrial dysfunction, glycolysis, inflammation, and programmed cell death among the four groups (Fig. 6I). Pearson correlation analysis revealed strong positive correlations among HIF-1α, HK2, PKM, LDH, DRP1, CHOP, p-PERK, inflammatory cytokines, and apoptosis-, necroptosis-, and pyroptosis-related markers, whereas MFN2, Bcl-2, and TGF-β showed opposite trends (Fig. 6J). The chord diagram further highlighted close associations among glycolytic dysregulation, mitochondrial dysfunction, inflammation, and PANoptosis-related molecular responses (Fig. 6K). Collectively, these findings suggest that HIF-1α-mediated glycolytic regulation is closely involved in DEHP-induced hepatic injury in chickens, and that curcumin may exert hepatoprotective effects partly by targeting HIF-1α and alleviating glycolytic abnormalities. Discussion The liver is a central metabolic organ responsible for nutrient metabolism, detoxification, antioxidant defense, and immune regulation in poultry (Alshamy et al., 2019; Amevor et al., 2025). Disruption of hepatic function during the early stages of growth can profoundly impair metabolic homeostasis, physiological development, and overall health status (Alshamy et al., 2019; Van Every and Schmidt, 2025). In the present study, exposure to di(2-ethylhexyl) phthalate (DEHP) reduced body weight gain, increased the liver index, elevated serum alanine aminotransferase and aspartate aminotransferase activities, and induced pronounced histological and ultrastructural liver damage in chicks. These pathological changes were accompanied by excessive oxidative stress and robust inflammatory responses, confirming that DEHP causes substantial hepatic injury in young chickens. Notably, curcumin supplementation alleviated these abnormalities, suggesting that curcumin may improve hepatic resistance to DEHP-induced damage. From the perspective of poultry health, these findings suggest that chronic exposure to environmental plasticizers may pose a significant threat to hepatic function during early development, whereas curcumin represents a promising nutritional bioactive compound for improving hepatic protection under contaminant stress. Oxidative stress and mitochondrial dysfunction were important features of DEHP-induced hepatic injury in this present study (Erkekoglu et al., 2014; Kumar et al., 2024). DEHP exposure increased malondialdehyde content and mitochondrial reactive oxygen species (ROS) accumulation, while reducing antioxidant enzyme activities, total antioxidant capacity, mitochondrial membrane potential, and adenosine triphosphate production. In addition, DEHP-induced oxidative stress was accompanied by increased dynamin-related protein 1 expression and decreased mitofusin 2 expression, suggesting that DEHP may disturb mitochondrial dynamics by promoting mitochondrial fission and inhibiting mitochondrial fusion. Curcumin supplementation effectively reduced oxidative stress, restored mitochondrial membrane potential and energy production, and partially reversed the alterations in mitochondrial dynamics-related proteins. Moreover, activation of ROS by sanguinarine chloride weakened the protective effects of curcumin in LMH cells. These results support that curcumin protects against DEHP-induced liver injury, at least partly, by suppressing excessive ROS accumulation, maintaining mitochondrial homeostasis, and preserving mitochondrial functional stability. A notable finding of this study was that DEHP exposure was closely associated with hypoxia-inducible factor 1 alpha (HIF-1α)-related glycolytic disorder. The liver relies on the coordinated mitochondrial oxidative phosphorylation and glycolysis to maintain energy balance (Rui, 2014). Under conditions of mitochondrial stress, cells may enhance glycolytic metabolism as an adaptive response to compensate for impaired energy production. However, persistent glycolytic activation may reflect metabolic dysfunction rather than effective compensation (Kim et al., 2006; Papandreou et al., 2006; Semenza, 2010). In the present study, DEHP exposure significantly increased the expression levels of HIF-1α and glycolysis-related enzymes, including hexokinase 2, pyruvate kinase M, and lactate dehydrogenase, while decreasing adenosine triphosphate content. These findings suggest that DEHP induced a glycolysis-biased metabolic shift accompanied by impaired energy homeostasis. Curcumin supplementation suppressed the expression of HIF-1α and glycolysis enzymes and restored adenosine triphosphate production. Furthermore, the addition of sanguinarine chloride partially abolished these effects, indicating that ROS accumulation may serve as an upstream regulator of HIF-1α-associated glycolytic activation. Therefore, inhibition of the ROS/HIF-1α signaling pathway may represent an important mechanism through which curcumin improves DEHP-induced hepatic metabolic disturbance. The results of network pharmacology, molecular docking, molecular dynamics simulation, and cellular thermal shift assay further supported the potential involvement of HIF-1α in the protective action of curcumin. The predicted target network identified HIF-1α as a key candidate target, while molecular docking and molecular dynamics simulation analyses indicated that curcumin could interact with HIF-1α and form a relatively stable complex. In addition, the cellular thermal shift assay demonstrated that curcumin altered the thermal stability of HIF-1α in cells. These findings suggest a potential interaction between curcumin and HIF-1α, supporting the possible role of HIF-1α as a molecular target involved in the hepatoprotective effects of curcumin. Programmed cell death is an important process involved in toxicant-induced tissue injury (Orrenius et al., 2011; Tak and Kim, 2023). In this study, DEHP exposure increased the expression of apoptosis-related caspase 3, necroptosis-related receptor-interacting serine/threonine-protein kinase 1 and mixed lineage kinase domain-like protein, as well as pyroptosis-related nucleotide-binding oligomerization domain-like receptor protein 3 and gasdermin D, while decreasing the expression of the anti-apoptotic protein B-cell lymphoma 2. These alterations indicate that DEHP activated multiple programmed cell death-related molecular responses in chick liver and LMH cells. Since apoptosis-, necroptosis-, and pyroptosis-related markers were simultaneously affected, the result suggests that DEHP-induced hepatic injury involves the coordinated regulation of multiple cell death-related pathways. Curcumin supplementation reduced the expression of these cell death-related markers, suggesting that its protective effect may be associated with the inhibition of excessive programmed cell death signaling. The use of sodium dichloroacetate further clarified the relationship between glycolytic disorder and cell death-related molecular responses. Sodium dichloroacetate partially mimicked the inhibitory effects of curcumin on the expression of caspase 3, receptor-interacting serine/threonine-protein kinase 1, mixed lineage kinase domain-like protein, nucleotide-binding oligomerization domain-like receptor protein 3, and gasdermin D, while restoring B-cell lymphoma 2 expression. These findings suggest that DEHP-induced glycolytic dysregulation may contribute to the activation of cell death-related molecular responses. Therefore, the ROS-HIF-1α-glycolysis axis may serve as an upstream regulatory pathway connecting mitochondrial oxidative stress with apoptosis-, necroptosis-, and pyroptosis-related molecular alterations in DEHP-exposed chicken liver cells. Several limitations should be considered when interpreting these present findings. First, although DEHP exposure simultaneously altered representative markers associated with apoptosis, necroptosis, and pyroptosis, the formation of PANoptosis-associated protein complexes was not directly investigated. Therefore, the current study provides evidence for PANoptosis-related molecular responses rather than confirming the complete activation of the PANoptosis pathway. Second, LMH cells were used as an in vitro model, which may not fully reflect the physiological characteristics and responses of primary chicken hepatocytes. Third, curcumin was administered by gavage rather than incorporated into a formulated diet, and its potential practical application as a feed additive requires further investigation. Future studies should evaluate dietary curcumin supplementation under production-relevant conditions, determine appropriate inclusion levels, and systematically assess its effects on growth performance, feed efficiency, liver function, antioxidant capacity, and contaminant resistance in poultry. In summary, DEHP-induced hepatic injury in chicks was closely associated with oxidative stress, mitochondrial dysfunction, HIF-1α-mediated glycolytic disorder, inflammation, and programmed cell death-related molecular responses. Curcumin effectively alleviated these changes by reducing mitochondrial ROS accumulation, preserving mitochondrial function, inhibiting HIF-1α-associated glycolytic activation, and attenuating apoptosis, necroptosis, and pyroptosis-related molecular responses. These findings provide mechanistic evidence supporting curcumin as a potential nutritional strategy for improving poultry liver health under environmental plasticizer exposure. Conclusions Curcumin alleviated di(2-ethylhexyl) phthalate-induced hepatic injury in chicks by improving antioxidant capacity, preserving mitochondrial function, suppressing hypoxia-inducible factor 1 alpha-associated glycolytic disorder, and reducing apoptosis, necroptosis, and pyroptosis-related molecular responses. These results indicate that oxidative stress-driven metabolic disturbances are closely involved in di(2-ethylhexyl) phthalate-induced hepatic damage in chickens. Curcumin may represent a potential nutritional strategy for supporting poultry liver health under environmental plasticizer exposure, although its practical application as a feed additive requires further validation under production conditions Funding This work was supported by the 10.13039/501100001809Natural Science Foundation of Heilongjiang Province, China [No. LH2023C020], the 10.13039/501100002863National Natural Science Foundation of China Youth Foundation [No. 31602028], the Natural Science Foundation of Heilongjiang Province [No. LH2022C043], the Postdoctoral Foundation of Heilongjiang Province [No. LBHQ19068]. Author Contribution Xiaoyu Zhao carried out the experimental work, organized and managed the resulting data, prepared the initial draft of the manuscript, and participated in its scientific revision. Bolin Zhao developed the experimental procedures, analyzed the study data, organized the resulting datasets, and participated in revising the manuscript. Bin Li contributed to the development of the experimental procedures and analyzed the study data. Rong Guo evaluated and confirmed the reliability of the experimental findings. Yue Liu contributed to the development of the experimental procedures, analyzed the study data, and participated in revising the manuscript. Li Liu evaluated and confirmed the reliability of the experimental findings. Yue Xu analyzed the study data. Guangxing Li conceived the study, developed the experimental approach, and provided overall scientific guidance throughout the research. Xiaodan Huang secured financial support for the study, oversaw the research, and critically revised the manuscript for important scientific content.All authors approved the final version of the manuscript. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.